APP and Alzheimer disease: Thus, the aim of the present study was to evaluate the possible therapeutic role and underlying mechanism of PNU-282987 in synapse dysfunction and the neuropathological process of AD using both primary hippocampus cells and APP/PS1_DT mice models.